Mohs surgery vs. radiation therapy for skin cancer

When a basal cell or squamous cell skin cancer is diagnosed, most patients expect to be sent straight to surgery. Many are surprised to learn there is a second path: radiation therapy, which destroys cancer cells with focused beams of energy over a series of appointments rather than removing them with a blade. Both can cure common skin cancers, but they work in opposite ways and suit different people, so it helps to understand the real trade-offs before deciding. The short version is that Mohs surgery is the standard of care for most skin cancers in cosmetically and functionally sensitive areas, while radiation is a valuable alternative for patients who cannot or should not have surgery.

How each treatment actually works. Mohs micrographic surgery removes the tumor one thin layer at a time and checks essentially the entire margin under a microscope before you leave, a process explained in what Mohs surgery is and why it has the highest cure rate. Radiation therapy, by contrast, does not remove tissue at all. It aims controlled doses of energy at the tumor across roughly fifteen to thirty short sessions over several weeks, damaging the cancer cells' ability to grow and divide until they die off. Surgery proves the cancer is gone the same day; radiation works gradually and the treated area is reassessed over the months that follow.

Cure rates favor surgery, but both are effective. For primary basal and squamous cell carcinomas, Mohs delivers cure rates around 99 percent, the highest of any treatment, because no tumor is left behind unseen. Radiation is also highly effective for appropriately selected tumors, with cure rates commonly reported in the low-to-mid 90 percent range, though it tends to trail surgery, especially for recurrent tumors or aggressive subtypes (National Cancer Institute). This gap is one reason the appropriate-use framework, covered in when Mohs is the right choice, and when it is not, points high-risk tumors toward surgery first.

Who radiation is really for. Radiation earns its place with patients for whom surgery is a poor fit: those who are very elderly or frail, who take medications that make surgery risky, or who have tumors in spots where a good surgical repair would be difficult. It is also used after surgery in select high-risk cases, for example when a tumor has spread along a nerve, to lower the odds of return. The American Academy of Dermatology notes that radiation is a reasonable option for older adults who prefer to avoid an operation, while surgery remains preferred for younger patients (American Academy of Dermatology).

Why age changes the calculation. Radiation carries a long tail. The treated skin can thin, scar, and develop new problems years later, and there is a small risk that the radiation itself seeds a future cancer in the same area decades on. That matters far less for an eighty-five-year-old than for a fifty-year-old, which is why guidelines generally steer younger patients toward surgery and reserve radiation for those whose life expectancy makes the delayed downsides irrelevant. Surgery's scar is immediate but stable; radiation's cosmetic result often looks good at first and can worsen over the years.

Time, convenience, and cost. The two treatments ask very different things of a patient's calendar. Mohs is usually one long day, described in what to expect on the day of Mohs surgery, after which the cancer is gone. Radiation trades that single day for many short visits spread across several weeks, which can mean a real transportation and scheduling burden for someone who lives far from a radiation center. Both are typically covered by insurance and Medicare as medically necessary cancer treatment, though the billing structures differ, a topic explored in what Mohs surgery costs, and what insurance actually covers.

What the recovery feels like. Surgery gives you a wound to care for and a scar that fades over months, with the aftercare laid out in the recovery coverage on this site. Radiation gives you no incision, but the treated skin often becomes red, sore, and irritated like a bad sunburn as the sessions accumulate, peaking near the end of the course and settling over the following weeks. Neither is painful in the way patients fear: Mohs is done under local anesthesia, and radiation sessions themselves are painless, with the discomfort coming from the skin reaction rather than the treatment.

How to decide with your doctor. The choice comes down to your tumor and your circumstances. Ask three questions: is my cancer a type and location where surgery gives the best cure rate, am I healthy enough that an outpatient procedure is low risk, and how many years do I need this result to hold up. For most people with a common skin cancer on the face, the answer points to Mohs. For a frail patient, a difficult location, or someone who genuinely cannot undergo surgery, radiation is a legitimate and effective alternative. Either way, seek a clinician who treats skin cancer routinely, using the due-diligence questions in finding a qualified Mohs surgeon, and understand which cancer type you are dealing with by reviewing basal cell vs. squamous cell carcinoma. The Skin Cancer Foundation maintains a plain-language overview of both approaches worth reading before the consult (Skin Cancer Foundation).

The takeaway. Mohs surgery and radiation therapy are both real cures for common skin cancers, not a first choice and a consolation prize. Surgery offers the highest cure rate, same-day certainty, and a stable result, which is why it leads for most patients. Radiation offers a non-surgical path that spares frail patients an operation, at the cost of many visits and downsides that surface over time. Matching the tool to the tumor and the person, rather than assuming one is always better, is exactly the reasoning a good skin cancer specialist will walk you through.

Related reading: When Mohs is the right choice, and when it is not.